another thing. It’s been proven to be substantially quicker acting than its competitors and far less side effects.
all of this information are good signs for American approval to limited release there. If it’s released there and well accepted, then
I think it’s game over as it’s the only company with the formula in the world.IMO the company testing Australian market first as it’s roots based here, but America their main target.
- Forums
- ASX - By Stock
- Life Science Review article
LTP
ltr pharma limited
Add to My Watchlist
3.45%
!
30.0¢

another thing. It’s been proven to be substantially quicker...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 407 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.290 |
1 | 24000 | 0.285 |
2 | 230000 | 0.280 |
5 | 137909 | 0.275 |
10 | 192157 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 9760 | 1 |
0.310 | 3286 | 1 |
0.315 | 9460 | 1 |
0.320 | 4762 | 2 |
0.325 | 79383 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online